CRO NACE Rev. 2 64.20 · IE · Founded 2018 · Accounts through 2024 · Updated Jul 26, 2026
See how companies in this sector are valued and what this company could be worth in five years. The benchmark is deliberately broad and based on sector data.
Is this your company? Claim and manage this profile
A deliberately broad indicative range built from comparable companies with stronger filed or size evidence. It is not a company-specific appraisal, market value, asking price, or offer.
Broad benchmark based on comparable companies in this sector — not a company-specific appraisalThe historical valuation curve is public. Create a free account for the future five-year growth forecast, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Public filings are a starting point. Owner-confirmed accounts, net debt, leases and commercial context can refine the range for a sale, financing or transfer.
This broad public curve is a starting point based on governed sector or size evidence. Create a free account to refine it with verified company data and see the five-year outlook with concrete action points.
Register your interest privately. Upswitch reviews every request and keeps it queued until a safe, verified owner contact route is available.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Claim this companyEMGEN THREE GP LIMITED, a CRO NACE Rev. 2 64.20, is registered at an address in Ireland. The company was founded in 2018, incorporated as a LTD - Private Company Limited by Shares.
EMGEN THREE GP LIMITED is listed in Irish Companies Registration Office (CRO) under registry number 639945.
Within the Irish NACE 64.20 cluster, public-record data is filed annually via the national company registry.
EMGEN THREE GP LIMITED's public curve tracks a deliberately broad p10-p90 sector benchmark based on at least 30 comparable companies with stronger filed or size evidence. Its centre line is only the arithmetic middle of the published band: not a company-specific appraisal, sale price, offer, or recommendation.
The most recent annual filing covers 2024 (period end 2024-12-31).
It is a sector-level research range, not a company-specific appraisal, market value, asking price, offer, or investment recommendation.
EMGEN THREE GP LIMITED was founded in 2018 and is registered with Irish Companies Registration Office (CRO), incorporated as a LTD - Private Company Limited by Shares.
EMGEN THREE GP LIMITED is registered under NACE 64.20: CRO NACE Rev. 2 64.20. That places the business within the Irish cluster for this activity.
The most recently filed annual accounts cover fiscal year 2024 (period end 2024-12-31), publicly available via Irish Companies Registration Office (CRO).
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for EMGEN THREE GP LIMITED may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
